The following stories appear in full on Today's Vidyya Medical News Service Web site.
A new system that makes daily blood glucose monitoring significantly less painful and more convenient for many people with diabetes has been introduced by LifeScan, a Johnson & Johnson company. Recently cleared by the U.S. Food and Drug Administration, the One Touch ® Ultra Blood Glucose Monitoring System is the first product to combine a less painful alternative to traditional fingerstick testing with the fastest test time and the broadest operating temperature range of any system available.
For more information: New Blood Glucose Testing System Helps Reduce Pain
Will the needle become a thing of the past in the life of the diabetic? It appears so. The same researchers who reported last week that inhaled insulin can control blood sugar as well as injected insulin in people with type 1 diabetes now report that inhaled insulin also appears promising as a treatment for type 2 diabetes, the more common form of the disease.
For more information: Inahled Insulin Appears To Be Effective For Type II Diabetes Patients
An implantable sensor that may one day be used to simultaneously monitor glucose and insulin levels in the blood to help patients with diabetes better manage their disease has been developmed by a group of researchers in New Mexico. Although not yet tested in diabetics, the researchers hope that it will become the standard of care for patients with diabetes.
For more information: Implantable Sensor May One Day Simultaneously Monitor Glucose And Insulin Levels
In this era of limited resources and escalating costs, it is critical to have an understanding of the economics of diabetes in order to develop and implement sound public health and prevention policies. This annotated bibliography can be a valuable review tool to help researchers access information regarding the economics of diabetes.
For more information: The Economics Of Diabetes Mellitus: An Annotated Bibliography
A vaccine that would inhibit the onset of Type I diabetes -- insulin dependent diabetes -- could be on the horizon for those at high risk of developing the disease, researchers at North Carolina at Chapel Hill said Wednesday.
For more information: Vaccine Could Prevent Type I Diabetes
Today's Vidyya articles are:
As always, we hope you enjoy the issue.